show more articles
of women in the workforce, supplemented by efforts to extend parental leave, help the industry become a leader in reconciling work and family life.
francs is the total of direct and indirect value added contributed by the pharmaceutical production and research activities. This corresponds to 9.3% of Switzerland's total economic output.
The pharmaceutical industry in Switzerland will also need attractive framework conditions in future, including legal certainty, open export markets and the availability of labour.
Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2020
More about the tasks and overriding aims of Interpharma
Latest information and media contacts for media representatives